128 related articles for article (PubMed ID: 11013662)
21. A cost-effectiveness analysis of docetaxel in the second-line treatment of non-small cell lung cancer.
Holmes J; Dunlop D; Hemmett L; Sharplin P; Bose U
Pharmacoeconomics; 2004; 22(9):581-9. PubMed ID: 15209527
[TBL] [Abstract][Full Text] [Related]
22. Economic implications of multiple births: inpatient hospital costs in the first 5 years of life.
Henderson J; Hockley C; Petrou S; Goldacre M; Davidson L
Arch Dis Child Fetal Neonatal Ed; 2004 Nov; 89(6):F542-5. PubMed ID: 15499151
[TBL] [Abstract][Full Text] [Related]
23. Cost effectiveness of day and inpatient psychiatric treatment: results of a randomised controlled trial.
Creed F; Mbaya P; Lancashire S; Tomenson B; Williams B; Holme S
BMJ; 1997 May; 314(7091):1381-5. PubMed ID: 9161310
[TBL] [Abstract][Full Text] [Related]
24. Malignant glioma.
Young B; Loughrige D; Furst RW; Costich J; Thornton BB; Engelberg J
South Med J; 1988 Feb; 81(2):238-42. PubMed ID: 3124274
[No Abstract] [Full Text] [Related]
25. Elective versus ruptured abdominal aortic aneurysm repair: a 1-year cost-effectiveness analysis.
Cota AM; Omer AA; Jaipersad AS; Wilson NV
Ann Vasc Surg; 2005 Nov; 19(6):858-61. PubMed ID: 16177868
[TBL] [Abstract][Full Text] [Related]
26. The use of CT scanning in dementia. A systematic review.
Foster GR; Scott DA; Payne S
Int J Technol Assess Health Care; 1999; 15(2):406-23. PubMed ID: 10507198
[TBL] [Abstract][Full Text] [Related]
27. Treatment by a specialist surgical neuro-oncologist does not provide any survival advantage for patients with a malignant glioma.
Latif AZ; Signorini DF; Whittle IR
Br J Neurosurg; 1998 Feb; 12(1):29-32. PubMed ID: 11013644
[TBL] [Abstract][Full Text] [Related]
28. Acute myeloblastic leukaemia--a model for assessing value for money for new treatment programmes.
Lobo PJ; Powles RL; Hanrahan A; Reynold DK
BMJ; 1991 Feb; 302(6772):323-6. PubMed ID: 1900453
[TBL] [Abstract][Full Text] [Related]
29. The OMENS trial: opportunistic evaluation of musculo-skeletal physician care among orthopaedic outpatients unlikely to require surgery.
Brown AP; Kennedy AD; Torgerson DJ; Campbell J; Webb JA; Grant AM
Health Bull (Edinb); 2001 May; 59(3):198-210. PubMed ID: 12664761
[TBL] [Abstract][Full Text] [Related]
30. Hospital service utilization by HIV/AIDS patients and their management cost in a provincial genitourinary medicine department.
Nageswaran A; Kinghorn GR; Shen RN; Priestley CJ; Kyi TT
Int J STD AIDS; 1995; 6(5):336-44. PubMed ID: 8547414
[TBL] [Abstract][Full Text] [Related]
31. Cost-utility analysis of physiotherapy treatment compared with physiotherapy advice in low back pain.
Rivero-Arias O; Gray A; Frost H; Lamb SE; Stewart-Brown S
Spine (Phila Pa 1976); 2006 May; 31(12):1381-7. PubMed ID: 16721304
[TBL] [Abstract][Full Text] [Related]
32. Management of glioblastoma: comparison of clinical practices and cost-effectiveness in two cohorts of patients (2008 versus 2004) diagnosed in a French university hospital.
Diebold G; Ducray F; Henaine AM; Frappaz D; Guyotat J; Cartalat-Carel S; Breant V; Fouquet A; Aulagner G; Honnorat J; Armoiry X
J Clin Pharm Ther; 2014 Dec; 39(6):642-8. PubMed ID: 25164371
[TBL] [Abstract][Full Text] [Related]
33. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
[TBL] [Abstract][Full Text] [Related]
34. Costs of dialysis for elderly people in the UK.
Grun RP; Constantinovici N; Normand C; Lamping DL;
Nephrol Dial Transplant; 2003 Oct; 18(10):2122-7. PubMed ID: 13679490
[TBL] [Abstract][Full Text] [Related]
35. Cost effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom.
Davies A; Ridley S; Hutton J; Chinn C; Barber B; Angus DC
Anaesthesia; 2005 Feb; 60(2):155-62. PubMed ID: 15644013
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
[TBL] [Abstract][Full Text] [Related]
37. What does GP out of hours care cost? An analysis of different models of out of hours care in Scotland.
Scott A; Simoens S; Heaney D; O'Donnell CA; Thomson H; Moffat KJ; Ross S; Drummond N
Scott Med J; 2004 May; 49(2):61-6. PubMed ID: 15209145
[TBL] [Abstract][Full Text] [Related]
38. Costs over time in conventional treatment of acute myeloid leukaemia. A study exploring changes in treatment strategies over two decades.
Stalfelt AM; Brodin H
J Intern Med; 1994 Oct; 236(4):401-9. PubMed ID: 7931043
[TBL] [Abstract][Full Text] [Related]
39. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
40. High-grade glioma in children and adolescents: a single-center experience.
Yazici G; Zorlu F; Cengiz M; Ozyigit G; Eren G; Yüce D; Varan A; Akyuz C; Akalan N; Gurkaynak M
Childs Nerv Syst; 2016 Feb; 32(2):291-7. PubMed ID: 26679932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
